Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Operating Expenses: 2017-2020

Historic Operating Expenses for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $11.5 million.

  • Cogent Biosciences' Operating Expenses fell 12.20% to $11.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was $90.1 million, marking a year-over-year increase of 64.73%. This contributed to the annual value of $90.1 million for FY2020, which is 64.73% up from last year.
  • According to the latest figures from Q4 2020, Cogent Biosciences' Operating Expenses is $11.5 million, which was down 80.08% from $57.5 million recorded in Q3 2020.
  • Over the past 5 years, Cogent Biosciences' Operating Expenses peaked at $57.5 million during Q3 2020, and registered a low of $7.9 million during Q1 2017.
  • Moreover, its 3-year median value for Operating Expenses was $12.9 million (2018), whereas its average is $15.9 million.
  • The largest annual percentage gain for Cogent Biosciences' Operating Expenses in the last 5 years was 340.49% (2020), contrasted with its biggest fall of 42.02% (2020).
  • Over the past 4 years, Cogent Biosciences' Operating Expenses (Quarterly) stood at $9.0 million in 2017, then surged by 42.27% to $12.8 million in 2018, then increased by 1.87% to $13.0 million in 2019, then decreased by 12.20% to $11.5 million in 2020.
  • Its Operating Expenses was $11.5 million in Q4 2020, compared to $57.5 million in Q3 2020 and $7.9 million in Q2 2020.